Supply Chain

Perspective

Navigating China IIT Importation Without Losing the Speed Advantage

Navigating China IIT Importation Without Losing the Speed Advantage

China IITs Are Unique and Operationally Challenging Across the Clinical Supply Chain China IITs can offer advanced therapy sponsors a…

Perspective

Quarantines, Complaints, Temperature Excursions & Other Debacles: Mitigating the Impact of Clinical Supply Disruption

While the best way to avoid clinical supply disruption is through careful planning and setting up a robust supply chain,…

Perspective

Image of vials as part of commercial supply chain launch gating strategies

Event Recap: Successful Gating Strategies When Building Your Commercial Supply Chain

Today’s landscape combines heightened uncertainty spanning scientific, regulatory, clinical, and operational risks with an economic environment where many emerging companies…

Info Sheet

Converge Consulting logo

Supply Risk Management Services & Support

Life science companies invest deeply in and rely heavily on their supply chain. This includes preparing for a growing list…

Perspective

Depot-to-Site Supply Strategy: 10 Key Considerations for Clinical Success

Depot-to-site clinical supply strategy ensures that the investigational product (IP) is available at the right site, in the right quantity,…

Perspective

Event Recap: Supply Risk Management in 2025

With geopolitical tensions creating significant instability in global supply chains, on top of continuing economic uncertainty and regulatory shifts, many…

Perspective

Navigating Tariff Volatility: Strategic Pathways for Emerging Life Sciences Companies

New perspective from Gartner highlights that Chief Supply Chain Officers must plan for long-term volatility, considering potential countermeasures, escalations, and de-escalations.…

Perspective

The Strategic Imperative of Supplier Risk Management for Biopharmaceuticals

In recent years, the biopharmaceutical industry has faced an increasingly complex and volatile supply chain risk landscape. The lasting effects…

Perspective

The BIOSECURE Act: Safeguarding U.S. Biotechnology

The BIOSECURE Act is a pivotal U.S. legislative measure designed to safeguard national security by restricting federal contracts and funding…

Perspective

349680977 | Supply Chain © Sirinporn Phaisri | Dreamstime.com

Event Recap: TraceLink FutureLink Barcelona Conference 2024

TraceLink recently hosted FutureLink Barcelona 2024, their annual European meeting for supply chain participants. Since Europe enacted serialization requirements back…

Perspective

The Evolving Ecosystem for Biopharma Manufacturing

A significant – even seismic – shift is taking place in biopharma manufacturing and technical operations right now. It is…

Perspective

Highlights from Navigating Serialization Compliance to Meet November’s FDA Enforcement Deadline Webinar

2024 is a crucial year for the life science industry. November marks the end of the DSCSA stabilization period and…

Perspective

Impact of Rejecting Chevron Deference on Biopharma

On June 28, the Supreme Court of the United States (SCOTUS) overruled the most cited legal case in its history, colloquially…

Perspective

Event Recap: FutureLink 2024

At the end of May 2024, TraceLink hosted its annual conference – FutureLink 2024. The event brings together manufacturers, brand…

Perspective

Drafting SOPs for a Facility that Does Not Exist Yet

When a biopharma company is bringing up a new manufacturing or warehouse facility, there are many standard operating processes/procedures (SOPs)…

Perspective

Last Mile Logistics: How Manufacturers Can Help Ensure Product Integrity for Patients

Last mile logistics, the final leg of the supply chain from distribution centers or pharmacies to the point of administration,…